DE2548638A1 - Verfahren zur vorhersage und bestimmung der ovulation und mittel zur durchfuehrung des verfahrens - Google Patents
Verfahren zur vorhersage und bestimmung der ovulation und mittel zur durchfuehrung des verfahrensInfo
- Publication number
- DE2548638A1 DE2548638A1 DE19752548638 DE2548638A DE2548638A1 DE 2548638 A1 DE2548638 A1 DE 2548638A1 DE 19752548638 DE19752548638 DE 19752548638 DE 2548638 A DE2548638 A DE 2548638A DE 2548638 A1 DE2548638 A1 DE 2548638A1
- Authority
- DE
- Germany
- Prior art keywords
- concentration
- lactic acid
- ovulation
- vaginal secretions
- organic compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000016087 ovulation Effects 0.000 title claims description 118
- 238000000034 method Methods 0.000 title claims description 113
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 188
- 239000004310 lactic acid Substances 0.000 claims description 94
- 235000014655 lactic acid Nutrition 0.000 claims description 94
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 78
- 210000003756 cervix mucus Anatomy 0.000 claims description 54
- 239000011230 binding agent Substances 0.000 claims description 46
- 241000124008 Mammalia Species 0.000 claims description 31
- 150000002894 organic compounds Chemical class 0.000 claims description 24
- 230000004044 response Effects 0.000 claims description 20
- 230000035558 fertility Effects 0.000 claims description 17
- 230000028327 secretion Effects 0.000 claims description 16
- 239000000126 substance Substances 0.000 claims description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 13
- 239000008103 glucose Substances 0.000 claims description 13
- 238000012544 monitoring process Methods 0.000 claims description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- 230000004720 fertilization Effects 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 7
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 claims description 6
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 6
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 6
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 6
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 claims description 6
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 6
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 claims description 6
- DUIOPKIIICUYRZ-UHFFFAOYSA-N semicarbazide Chemical compound NNC(N)=O DUIOPKIIICUYRZ-UHFFFAOYSA-N 0.000 claims description 6
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 claims description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000012855 volatile organic compound Substances 0.000 claims description 5
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 claims description 3
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 claims description 3
- 239000005711 Benzoic acid Substances 0.000 claims description 3
- 101710088194 Dehydrogenase Proteins 0.000 claims description 3
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims description 3
- 235000010233 benzoic acid Nutrition 0.000 claims description 3
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims description 3
- 239000013043 chemical agent Substances 0.000 claims description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 3
- 238000005470 impregnation Methods 0.000 claims description 3
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 3
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 3
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims description 3
- 229940100595 phenylacetaldehyde Drugs 0.000 claims description 3
- 235000019260 propionic acid Nutrition 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 241000252254 Catostomidae Species 0.000 claims 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 claims 2
- APLCZKIBRHKENK-UHFFFAOYSA-J cerium(4+) disulfite Chemical compound [Ce+4].[O-]S([O-])=O.[O-]S([O-])=O APLCZKIBRHKENK-UHFFFAOYSA-J 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 229960000448 lactic acid Drugs 0.000 description 70
- 238000012360 testing method Methods 0.000 description 29
- 239000000262 estrogen Substances 0.000 description 28
- 229940011871 estrogen Drugs 0.000 description 28
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 24
- 239000002253 acid Substances 0.000 description 18
- 230000000624 ovulatory effect Effects 0.000 description 18
- 230000036760 body temperature Effects 0.000 description 16
- 230000027758 ovulation cycle Effects 0.000 description 16
- 239000000186 progesterone Substances 0.000 description 12
- 229960003387 progesterone Drugs 0.000 description 12
- 150000007513 acids Chemical class 0.000 description 9
- 102000009151 Luteinizing Hormone Human genes 0.000 description 8
- 108010073521 Luteinizing Hormone Proteins 0.000 description 8
- 229940088597 hormone Drugs 0.000 description 8
- 239000005556 hormone Substances 0.000 description 8
- 229940040129 luteinizing hormone Drugs 0.000 description 8
- 230000029849 luteinization Effects 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 230000001568 sexual effect Effects 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- 210000001215 vagina Anatomy 0.000 description 6
- 241000282412 Homo Species 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000033764 rhythmic process Effects 0.000 description 5
- 150000003431 steroids Chemical class 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241000283086 Equidae Species 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000001076 estrogenic effect Effects 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 241000282560 Macaca mulatta Species 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000003679 cervix uteri Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000002357 endometrial effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 230000000938 luteal effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010065347 Premenstrual pain Diseases 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 206010053459 Secretion discharge Diseases 0.000 description 1
- 206010058679 Skin oedema Diseases 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 241000656145 Thyrsites atun Species 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 125000000218 acetic acid group Chemical class C(C)(=O)* 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- OZECDDHOAMNMQI-UHFFFAOYSA-H cerium(3+);trisulfate Chemical compound [Ce+3].[Ce+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O OZECDDHOAMNMQI-UHFFFAOYSA-H 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000007705 chemical test Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 210000004246 corpus luteum Anatomy 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 229940059082 douche Drugs 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 231100000547 follicle rupture Toxicity 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000007483 microbial process Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000000136 postovulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0012—Ovulation-period determination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D17/00—Devices for indicating trouble during labour of animals ; Methods or instruments for detecting pregnancy-related states of animals
- A61D17/002—Devices for indicating trouble during labour of animals ; Methods or instruments for detecting pregnancy-related states of animals for detecting period of heat of animals, i.e. for detecting oestrus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B2010/0003—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements including means for analysis by an unskilled person
- A61B2010/0006—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements including means for analysis by an unskilled person involving a colour change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/906—Fertility tests
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/20—Oxygen containing
- Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
- Y10T436/201666—Carboxylic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Surgery (AREA)
- Pregnancy & Childbirth (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Surgical Instruments (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/519,220 US3986494A (en) | 1974-10-30 | 1974-10-30 | Method of predicting and detecting ovulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2548638A1 true DE2548638A1 (de) | 1976-05-13 |
Family
ID=24067389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19752548638 Pending DE2548638A1 (de) | 1974-10-30 | 1975-10-30 | Verfahren zur vorhersage und bestimmung der ovulation und mittel zur durchfuehrung des verfahrens |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3986494A (enExample) |
| JP (1) | JPS5170994A (enExample) |
| AU (1) | AU8618975A (enExample) |
| CA (1) | CA1055370A (enExample) |
| DE (1) | DE2548638A1 (enExample) |
| FR (1) | FR2299005A1 (enExample) |
| ZA (1) | ZA756647B (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0095079A1 (en) * | 1982-05-07 | 1983-11-30 | University Patents, Inc. | Method and apparatus for detection of fertility |
| US5109865A (en) * | 1988-07-29 | 1992-05-05 | Kabushiki Kaisha Semex Japan | Method and apparatus for examining ovary and diagnosing the presence of pregnancy in mammals |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4334540A (en) * | 1979-05-01 | 1982-06-15 | Monell Chemical Senses Center | Method of diagnosing periodontal disease through the detection of pyridine compounds |
| US4385125A (en) * | 1980-11-14 | 1983-05-24 | Monell Chemical Senses Center | Method detecting ovulation by monitoring dodecanol concentration in saliva |
| US4390633A (en) * | 1981-07-24 | 1983-06-28 | The Curators Of The University Of Missouri | Determining reproductive status of mammals with NMR of cervical mucus |
| US4358288A (en) * | 1981-09-16 | 1982-11-09 | Goldman Dorothee F E | Fertility indicator system containing anthocyanin pigment |
| US4465077A (en) * | 1981-11-12 | 1984-08-14 | Howard Schneider | Apparatus and method of determining fertility status |
| US4467814A (en) * | 1982-03-19 | 1984-08-28 | Monell Chemical Senses Center | Method for detecting bovine estrus by determining methyl heptanol concentrations in vaginal secretions |
| US5155045A (en) * | 1985-01-25 | 1992-10-13 | Trustees Of The University Of Penn. | Use of male essence to alter female endocrine response |
| US4931403A (en) * | 1985-01-25 | 1990-06-05 | Monell Chemical Senses Center | Axillary androstenol and dehydroepiandrosterone as fertile period onset indicators |
| US4670401A (en) * | 1985-01-25 | 1987-06-02 | Monell Chemical Senses Center | Axillary androstenol and dehydroepiandrosterone as fertile period onset indicators |
| US4879244A (en) * | 1985-01-25 | 1989-11-07 | Monell Chemical Senses Center | Birth control method involving monitoring of axillary androstenol and dehydroepiandrosterone |
| GB9217808D0 (en) * | 1992-08-21 | 1992-10-07 | Unilever Plc | Advisory method |
| GB9217864D0 (en) * | 1992-08-21 | 1992-10-07 | Unilever Plc | Monitoring method |
| AU759245B2 (en) * | 1992-08-21 | 2003-04-10 | Inverness Medical Switzerland Gmbh | Monitoring method |
| GB9217865D0 (en) | 1992-08-21 | 1992-10-07 | Unilever Plc | Monitoring method |
| US7141212B2 (en) | 1993-11-12 | 2006-11-28 | Inverness Medical Switzerland Gmbh | Reading devices and assay devices for use therewith |
| US6451619B1 (en) | 1994-06-29 | 2002-09-17 | Inverness Medical Switzerland Gmbh | Monitoring methods and devices for use therein |
| US6927064B1 (en) * | 1994-06-29 | 2005-08-09 | Inverness Medical Switzerland Gmbh | Fertility computing method |
| US5721142A (en) * | 1994-08-22 | 1998-02-24 | Texas A & M University System | Method for monitoring mammalian reproductive cycles |
| US5762614A (en) * | 1994-08-25 | 1998-06-09 | Caillouette; James C. | Estrogen or estradiol need determination by vaginal acidity determination |
| US5725481A (en) | 1996-05-17 | 1998-03-10 | A. Fem Medical Corporation | Method and apparatus for collecting vaginal fluid and exfoliated vaginal cells for diagnostic purposes |
| ATE213333T1 (de) * | 1996-09-27 | 2002-02-15 | Unilever Nv | Überwachungsverfahren |
| DE69626016T2 (de) * | 1996-09-27 | 2004-01-08 | Inverness Medical Switzerland Gmbh | Test-Kit und Vorrichtungen |
| US6479015B1 (en) | 1998-03-03 | 2002-11-12 | Pepex Biomedical, Llc | Apparatus for monitoring a level of a chemical species in a body fluid |
| GB9807134D0 (en) | 1998-04-02 | 1998-06-03 | Unilever Plc | Test methods devices and test kits |
| WO2012125650A1 (en) | 2011-03-14 | 2012-09-20 | Valley Electronics Llc | Portable preprogrammed thermometer for indicating fertility status |
| WO2018077998A1 (en) * | 2016-10-27 | 2018-05-03 | Ava Ag | System and a method for non-invasive monitoring of estrogen |
| EP3335638A1 (en) | 2016-12-13 | 2018-06-20 | Colorimetrix GmbH | Method and device for estimation of ovulation date |
| WO2019008970A1 (ja) * | 2017-07-07 | 2019-01-10 | パナソニックＩｐマネジメント株式会社 | 情報提供方法、情報処理システム、情報端末、及び情報処理方法 |
| CN110537097B (zh) * | 2017-07-07 | 2022-03-08 | 松下知识产权经营株式会社 | 信息提供方法、信息处理系统、信息终端及信息处理方法 |
| WO2021016581A1 (en) | 2019-07-25 | 2021-01-28 | Overture Life, Inc. | Identification of viable human embryos |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3037496A (en) * | 1959-08-03 | 1962-06-05 | Frederick J Melges | Fertility testing apparatus |
| US3406016A (en) * | 1965-02-01 | 1968-10-15 | Raymond O. Foster | Means for detecting the fertile period |
| US3406015A (en) * | 1965-02-01 | 1968-10-15 | Raymond O. Foster | Means for detecting the fertile period |
| US3472738A (en) * | 1967-06-12 | 1969-10-14 | Weston Lab Inc | Test implement for detecting peroxidase |
| US3842166A (en) * | 1973-02-05 | 1974-10-15 | Microbyx Corp | Method and device for testing for the presence of micro-organisms |
-
1974
- 1974-10-30 US US05/519,220 patent/US3986494A/en not_active Expired - Lifetime
-
1975
- 1975-10-22 ZA ZA00756647A patent/ZA756647B/xx unknown
- 1975-10-30 DE DE19752548638 patent/DE2548638A1/de active Pending
- 1975-10-30 JP JP50129968A patent/JPS5170994A/ja active Pending
- 1975-10-30 CA CA238,645A patent/CA1055370A/en not_active Expired
- 1975-10-30 AU AU86189/75A patent/AU8618975A/en not_active Expired
- 1975-10-30 FR FR7533147A patent/FR2299005A1/fr active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0095079A1 (en) * | 1982-05-07 | 1983-11-30 | University Patents, Inc. | Method and apparatus for detection of fertility |
| US5109865A (en) * | 1988-07-29 | 1992-05-05 | Kabushiki Kaisha Semex Japan | Method and apparatus for examining ovary and diagnosing the presence of pregnancy in mammals |
Also Published As
| Publication number | Publication date |
|---|---|
| AU8618975A (en) | 1977-05-05 |
| FR2299005B1 (enExample) | 1979-01-12 |
| ZA756647B (en) | 1976-09-29 |
| JPS5170994A (enExample) | 1976-06-19 |
| FR2299005A1 (fr) | 1976-08-27 |
| US3986494A (en) | 1976-10-19 |
| CA1055370A (en) | 1979-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2548638A1 (de) | Verfahren zur vorhersage und bestimmung der ovulation und mittel zur durchfuehrung des verfahrens | |
| US4010738A (en) | Method of predicting and detecting ovulation | |
| DE69308147T2 (de) | Überwachungsverfahren und test kits | |
| DE3850504T2 (de) | Verfahren und vorrichtung zum bestimmen der heilfähigkeit einer operationswunde. | |
| DE69308858T2 (de) | Überwachungsverfahren, vorrichtungen und test kits | |
| US4670401A (en) | Axillary androstenol and dehydroepiandrosterone as fertile period onset indicators | |
| US4036212A (en) | Method of predetermining time of ovulation in women and in animals to control conception | |
| DE69632645T2 (de) | Vorrichtung und verfahren zur bestimmung des fruchtbarkeitsstatus von frauen | |
| Corner | Oestrus, ovulation and menstruation | |
| US5155045A (en) | Use of male essence to alter female endocrine response | |
| DE69718169T2 (de) | Test zur diagnose von schizophrenie mittels niacin | |
| DE10112470A1 (de) | Verfahren zur Proben-Identifizierung bei einem Säugetier sowie ein Kit zur Durchführung dieses Verfahrens | |
| DE2548868C2 (de) | Verfahren zur Bestimmung von Schwangerschaftshormonen | |
| Buijtels et al. | Effects of gonadotrophin releasing hormone administration on the pituitary‐ovarian axis in anoestrous vs ovariectomized bitches | |
| Hunter et al. | The effects of total oestrogen concentration and menstrual-cycle phase on reaction time performance | |
| DE3140265A1 (de) | Verfahren und vorrichtung zum nachweis der konzeptionsbereitschaft von weiblichen saeugern | |
| DE1598199A1 (de) | Testmethode zur Bestimmung der Ovularfunktionen | |
| Mastroianni Jr et al. | Some observations on fallopian tube fluid in the monkey | |
| DE3789302T2 (de) | Verfahren und Vorrichtung zum Erkennen des Zeitpunkts des Eisprungs bei Frauen durch Messen der Viscoelastizität vom Speichel. | |
| Friedgood et al. | The Assay of Crystalline and Urinary Androgens: With Special Reference to Their Measurement by a Colorimetric Method | |
| Raeside et al. | Arborization of cervical mucus in the ewe | |
| EP3786977A1 (de) | Computerimplementiertes verfahren und elektronisches system zur prognose eines entbindungszeitpunkts | |
| US4879244A (en) | Birth control method involving monitoring of axillary androstenol and dehydroepiandrosterone | |
| EP0857974A1 (de) | Schnelltest zur Progesteronbestimmung in Milch | |
| Szarka et al. | A study of the ratio of the amount of theelin producing uterine and vaginal estrus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHJ | Non-payment of the annual fee |